Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials

AB Tullo; B Esmaeli; Philip Murray; E Bristow; BJ Forsythe; K Faulkner

doi:10.1038/sj.eye.6701630

Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials

AB Tullo
, B Esmaeli
, Philip Murray
, E Bristow
, BJ Forsythe
, K Faulkner

Immunology and Immunotherapy

Research output: Contribution to journal › Article

41 Citations (Scopus)

Original language	English
Pages (from-to)	729-38
Number of pages	10
Journal	Eye
Volume	19
DOIs	https://doi.org/10.1038/sj.eye.6701630
Publication status	Published - 28 Jan 2005

Access to Document

10.1038/sj.eye.6701630

Cite this

@article{987522b4c8114584984aeaefd1b04ee3,

title = "Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ({\textquoteleft}Iressa{\textquoteright}, ZD1839) in Phase I and II clinical trials",

author = "AB Tullo and B Esmaeli and Philip Murray and E Bristow and BJ Forsythe and K Faulkner",

year = "2005",

month = jan,

day = "28",

doi = "10.1038/sj.eye.6701630",

language = "English",

volume = "19",

pages = "729--38",

journal = "Eye",

issn = "1476-5454",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials

AU - Tullo, AB

AU - Esmaeli, B

AU - Murray, Philip

AU - Bristow, E

AU - Forsythe, BJ

AU - Faulkner, K

PY - 2005/1/28

Y1 - 2005/1/28

UR - https://www.scopus.com/pages/publications/22744451123

U2 - 10.1038/sj.eye.6701630

DO - 10.1038/sj.eye.6701630

M3 - Article

C2 - 15688060

SN - 1476-5454

VL - 19

SP - 729

EP - 738

JO - Eye

JF - Eye

ER -